A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma

Trial Identifier: D7400C00006
Sponsor: AstraZeneca
Collaborator:
N/A
Start Date: March 2021
Primary Completion Date: April 2028
Study Completion Date: April 2028

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AU Bedford Park, AU, 5042
AU Heidelberg, AU, 3084
AU Hobart, AU, 7000
AU Melbourne, AU, 3004
JP Chuo-ku, JP, 104-0045
JP Koto-ku, JP, 135-8550
JP Nagoya-shi, JP, 460-0001
JP Yamagata-shi, JP, 990-9585
KR Seoul, KR, 06591
KR Seoul, KR, 05505
KR Seoul, KR, 120-752
KR Seoul, KR, 03080
KR Seoul, KR, 06351
TW Kaohsiung, TW, 833401
TW Kweishan, TW, 333
TW Tainan, TW, 704
TW Taipei, TW, 10002
US, FL Tampa, FL, US, 33612
US, KY Louisville, KY, US, 40207
US, NC Charlotte, NC, US, 28204
US, NJ New Brunswick, NJ, US, 08901
US, OH Columbus, OH, US, 43210
US, PA Pittsburgh, PA, US, 15237
US, TX Austin, TX, US, 78704
US, TX Houston, TX, US, 77030
US, WI Milwaukee, WI, US, 53226